OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.330
-0.030 (-2.21%)
At close: Sep 21, 2026, 4:00 PM EDT
1.340
+0.010 (0.75%)
After-hours: Sep 21, 2026, 7:30 PM EDT
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $69.8 million as of September 21, 2026. Its market cap has decreased by -6.27% in one year.
Market Cap
69.80M
Enterprise Value
49.20M
1-Year Change
-6.27%
Ranking
Category
Stock Price
$1.33
ChartMarket Cap Chart
Since the IPO on May 17, 2022, OKYO Pharma's market cap has decreased from $86.61M to $69.80M, a decrease of -19.41%. That is a compound annual growth rate of -4.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 69.80M | -10.35% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -50.99% |
| May 17, 2022 | 86.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 76.45M |
| RenovoRx | 76.27M |
| Cingulate | 76.20M |
| Kalaris Therapeutics | 76.18M |
| Champions Oncology | 73.77M |
| Alterity Therapeutics | 70.60M |
| Eloxx Pharmaceuticals | 70.44M |
| Rein Therapeutics | 69.01M |